Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
Publication

Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?

Title
Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
Type
Another Publication in an International Scientific Journal
Year
2015
Authors
Lima, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
José Bernardes
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Azevedo, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rui Medeiros
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Seabra, V
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 16
Pages: 13760-13780
ISSN: 1661-6596
Publisher: MDPI
Other information
Authenticus ID: P-00G-CPW
Abstract (EN): Background: Methotrexate (MTX) is widely used for rheumatoid arthritis (RA) treatment. Single nucleotide polymorphisms (SNPs) could be used as predictors of patients' therapeutic outcome variability. Therefore, this study aims to evaluate the influence of SNPs in genes encoding for MTX membrane transport proteins in order to predict clinical response to MTX. Methods: Clinicopathological data from 233 RA patients treated with MTX were collected, clinical response defined, and patients genotyped for 23 SNPs. Genotype and haplotype analyses were performed using multivariate methods and a genetic risk index (GRI) for non-response was created. Results: Increased risk for non-response was associated to SLC22A11 rs11231809 T carriers; ABCC1 rs246240 G carriers; ABCC1 rs3784864 G carriers; CGG haplotype for ABCC1 rs35592, rs2074087 and rs3784864; and CGG haplotype for ABCC1 rs35592, rs246240 and rs3784864. GRI demonstrated that patients with Index 3 were 16-fold more likely to be non-responders than those with Index 1. Conclusions: This study revealed that SLC22A11 and ABCC1 may be important to identify those patients who will not benefit from MTX treatment, highlighting the relevance in translating these results to clinical practice. However, further validation by independent studies is needed to develop the field of personalized medicine to predict clinical response to MTX treatment.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 21
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Of the same journal

Vanadium Compounds with Antidiabetic Potential (2023)
Another Publication in an International Scientific Journal
Amaral, LMPF; Moniz, T; Silva, AMN; Maria Rangel
Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis (2019)
Another Publication in an International Scientific Journal
Ferreira, N; Maria Joao Saraiva; Almeida, MR
Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways (2022)
Another Publication in an International Scientific Journal
Correia, AS; Nuno Vale
Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems (2019)
Another Publication in an International Scientific Journal
Souto, EB; Dias Ferreira, J; Oliveira, J; Sanchez Lopez, E; Lopez Machado, A; Espina, M; Garcia, ML; Souto, SB; Martins Gomes, C; Silva, AM
The Therapeutic Potential of Apigenin (2019)
Another Publication in an International Scientific Journal
Salehi, B; Venditti, A; Sharifi Rad, M; Kregiel, D; Sharifi Rad, J; Durazzo, A; Lucarini, M; Santini, A; Souto, EB; Novellino, E; Antolak, H; Azzini, E; Setzer, WN; Martins, N

See all (246)

Recommend this page Top